Cinemark (CNK) Stock Valuation Check After Recent Share Price Momentum

Cinemark Holdings, Inc.

Cinemark Holdings, Inc.

CNK

0.00

Recent share performance and business snapshot

Cinemark Holdings (CNK) has drawn fresh attention after a recent run in the stock, with the share price at $33.80 and returns of 29% over the past month and 31% over the past 3 months.

Short term momentum is clearly positive, with an 8.23% 7 day share price return and 28.57% 30 day share price return, while the 5 year total shareholder return of 57.37% reflects a much longer rebuild in value.

If recent moves in Cinemark have you thinking about what else is moving, it could be a good time to scan 20 top founder-led companies for fresh stock ideas.

With Cinemark shares up strongly in recent months and trading at $33.80, with an intrinsic value estimate implying a 21% discount and a small 3% gap to analyst targets, investors may ask whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 6% Overvalued

The most followed narrative puts Cinemark’s fair value at $31.82, slightly below the current $33.80 share price, which points to a mild premium based on long term assumptions rather than short term trading moves.

Analysts have nudged their price targets for Cinemark higher, with a range now stretching from $22 to $36. This reflects updated views on future box office trends, margin potential, and the company’s ability to sustain stronger per capita spending as film supply normalizes.

Want to see what is really driving that fair value gap? The narrative leans heavily on steady revenue growth, firmer margins and a richer future earnings multiple. The detailed assumptions behind those moving parts are where the story gets interesting.

Result: Fair Value of $31.82 (OVERVALUED)

However, this story can change quickly if film slates soften or if inflation and high fixed costs squeeze margins more than current assumptions allow.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another angle: cash flow points the other way

Cinemark might screen as 6% overvalued on the narrative fair value of $31.82, but the SWS DCF model paints a different picture, with an estimate of $42.77 per share, about 21% above the current $33.80 price. So which signal should carry more weight: the story or the cash flow math?

CNK Discounted Cash Flow as at Jun 2026
CNK Discounted Cash Flow as at Jun 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Cinemark Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment in this article pulling in both directions, now is a good time to review the data yourself, weigh the risks against the potential rewards, and see how the balance of 2 key rewards and 3 important warning signs fits with your own view.

Looking for more investment ideas?

If Cinemark has sharpened your focus on opportunities, now is the moment to broaden your watchlist and size up other potential candidates before the crowd catches on.

  • Spot potential mispricings early by scanning companies that look cheap on quality and valuation using the 44 high quality undervalued stocks.
  • Strengthen your income mindset by reviewing stocks with higher yields through the 8 dividend fortresses.
  • Prioritise resilience by checking companies with healthier balance sheets and fundamentals via the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.